As on 15-Dec-2022 09:30 EDT
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Research Alliance Corp II (RACB)
| 3.43 | 0.75 | 2.90 | 2.17 | -- | -- | -- |
S&P BSE Finance*
| 7.16 | 1.81 | 3.00 | 9.88 | 24.57 | 10.94 | -- |
S&P Small-Cap 600#
| -0.96 | -4.96 | -1.70 | 6.06 | 11.70 | 1.31 | 6.60 |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
Stock
|
Peer Median
|
||
---|---|---|---|
Please wait... |
The total asset value of Research Alliance Corp II (RACB) stood at $ 151 Mln as on 30-Sep-22
The share price of Research Alliance Corp II (RACB) is $10.105000 (NASDAQ) as of 15-Dec-2022 09:30 EDT. Research Alliance Corp II (RACB) has given a return of 2.17% in the last 1 years.
Research Alliance Corp II (RACB) has a market capitalisation of $ 194 Mln as on 13-Jan-2023. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Research Alliance Corp II (RACB) is 1.33 times as on 13-Jan-2023, a 0.1% premium to its peers’ median range of 1.21 times.
The P/E ratio of Research Alliance Corp II (RACB) is 168.42 times as on 13-Jan-2023, a 2.1% premium to its peers’ median range of 54.30 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Research Alliance Corp II (RACB) and enter the required number of quantities and click on buy to purchase the shares of Research Alliance Corp II (RACB).
Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada.
The CEO & director of Dr. Peter Kolchinsky Ph.D.. is Research Alliance Corp II (RACB), and CFO & Sr. VP is Dr. Matthew Hammond M.B.A., Ph.D..
The promoters of Research Alliance Corp II (RACB) have pledged 0% of the total equity as on Sep-22.
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
173
|
|
58
|
|
58
|
|
58
|
Research Alliance Corp II (RACB) | Ratios |
---|---|
Return on equity(%)
|
0.04
|
Return on capital employed(%)
|
--
|
Debt-to-equity ratio
|
0
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Research Alliance Corp II (RACB) was $0 Mln.
Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It... identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada. Read more
Unlimited access to advice from India's top experts
The most comprehensive analysis of funds and stocks in India
A holistic portfolio manager to help track all your investments easily
And much more, like guides, tools, webinars, videos and eBooks.